发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF SGLT2 DPP-IV |
摘要 |
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. |
申请公布号 |
HK1213820(A1) |
申请公布日期 |
2016.07.15 |
申请号 |
HK20160101977 |
申请日期 |
2012.02.22 |
申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
EICKELMANN, Peter P;MARK, Michael M;SEMAN, Leo John LJ;THOMAS, Leo L;BROEDL, Uli U;GREMPLER, Rolf R |
分类号 |
A61K;A61P |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|